Clinical Benefit of 11C Methionine PET Imaging as a Planning Modality for Radiosurgery of Previously Irradiated Recurrent Brain Metastases
Authors:
- Tadashi NariaiTNTadashi Nariai
- Takuya KawabeTKTakuya Kawabe
- Motoki InajiMIMotoki Inaji
- Yoji TanakaYTYoji Tanaka
- Shinya WatanabeSWShinya Watanabe
- Taketoshi MaeharaTMTaketoshi Maehara
- Keiichi OdaKOKeiichi Oda
- Kenji IshiiKIKenji Ishii
- Kiichi IshiwataKIKiichi Ishiwata
- Masaaki YamamotoMYMasaaki Yamamoto
- 1 November 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (11) , 939-943
Abstract
Stereotactic radiosurgery with gamma knife (GK-SRS) generally improves the focal control of brain metastases. Yet in cases of focal recurrence at a previous radiation site, MRI is often imperfect in differentiating between active tumor and radiation injury. We have examined whether the use of C methionine (MET) with PET will facilitate this differentiation and improve the outcome of GK-SRS for focally recurrent brain metastases after prior treatment. Eighty-eight patients underwent GK-SRS for postirradiation recurrent brain metastases. Thirty-four patients received radiation in areas manifesting high MET uptake (PET group) in a dose-planning procedure using MET-PET/MRI fusion images. Fifty-four patients referred from other institutes received radiation based on dose planning information obtained from MRI (MRI group). Sex, age, and the ratio of breast cancer differed significantly between the MRI and PET groups. The total irradiation volume was significantly smaller in the PET group, and the minimal irradiation dose was significantly higher. In a multivariable statistical analysis, the use of MET-PET (P = 0.02) was independently associated with prolonged overall survival after treatment, Karnofsky performance status (P = 0.002), the number of lesions (P = 0.03), and patient's sex (P = 0.02). The median survival time was significantly longer in the PET group (18.1 months) than in the MRI group (8.6 months) (P = 0.01). 11C methionine-PET/MRI fusion images for dose planning lengthened survival in patients undergoing GK-SRS for focally recurrent brain metastases.Keywords
This publication has 30 references indexed in Scilit:
- Stereotactic biopsy combined with stereotactic 125iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastasesJournal of Neuro-Oncology, 2011
- A Comparison of Radiotherapy with Radiotherapy plus Surgery for Brain Metastases from Urinary Bladder CancerStrahlentherapie und Onkologie, 2010
- Stereotactic Radiosurgery for the Management of Brain MetastasesNew England Journal of Medicine, 2010
- Outcome of Moderately Dosed Radiosurgery for Limited Brain MetastasesStrahlentherapie und Onkologie, 2010
- Outcome of repeated radiosurgery for recurrent metastatic brain tumorsClinical Neurology and Neurosurgery, 2007
- Usefulness ofl-[methyl-11C] methionine—positron emission tomography as a biological monitoring tool in the treatment of gliomaJournal of Neurosurgery, 2005
- Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Gamma Knife Radiosurgery for Metastatic Brain Tumor: The Usefulness of Repeated Gamma Knife Radiosurgery for Recurrent CasesStereotactic and Functional Neurosurgery, 1999
- MR Imaging Response of Brain Metastases after Gamma Knife Stereotactic RadiosurgeryRadiology, 1999
- Stereotactic radiosurgery VIII. The classification of postradiation reactionsBritish Journal Of Neurosurgery, 1999